Cepharadione B is primarily studied for its potential biological activities, particularly in the field of anti-inflammatory and anticancer research. It has shown inhibitory effects on certain pro-inflammatory mediators, making it a candidate for development in treating inflammatory diseases. Additionally, it exhibits cytotoxic activity against various cancer cell lines, suggesting its role as a lead compound in anticancer drug discovery. Its natural origin and unique diterpenoid structure contribute to its pharmacological interest, especially in exploring new therapeutic agents from plant sources.